UNSPSC 51182423: Ibandronate or ibandronic acid

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C9H23NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UMD7G2653W, chemically known as phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- but generally known as ibandronic acid, which bears US NIH Compound Identifier 60852. European Medicines Agency schedules Ibandronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08092MIG.

UNSPSC 51182423 Ibandronate or ibandronic acid is a Commodity code that spans pharmaceutical products supplied to state and local health and human services agencies, correctional departments, and cooperative purchasing consortiums. Recent state and local solicitations under this code show demand for generic pharmaceuticals and specialty medicines distributed through established wholesaler networks and direct-to-provider channels. The issuing bodies include state departments of health and human services, county correctional supervision agencies, and multistate cooperative purchasing alliances serving participating state and local facilities. Work being solicited ranges from bulk pharmaceutical supply agreements with price-based evaluation and compliance certification (Good Manufacturing Practices, Drug Supply Chain Security Act compliance) to specialized testing and specimen-collection services that may incorporate pharmaceutical screening and analysis components.

Recent activity spans Texas and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, seeking manufacturers to supply through three authorized wholesalers with contract effectiveness July 1, 2026. The Texas Health and Human Services Commission posted Request for Information HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager and wholesaler channels. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, with estimated contract value of $600,000) that includes immunoassay screening, LC/MS/MS confirmation, and ancillary testing across two collection sites in Plano and McKinney. Contract terms typically run two to five years with optional renewal periods, and evaluation prioritizes vendor qualifications and compliance certification alongside cost.